A New Service to Strengthen Organizational Culture from the Inside Out
Read MoreManhattan Bio Announces Successful Validation Of Novel Legumain-Cleavable TOP1i ADC Platform
Manhattan BioSolutions Secures Expanded Rights to Novel Legumain-Cleavable Topoisomerase 1 inhibitor (TOP1i) ADC Platform After Successful Multi-Target Validation
Read MoreLarge Strategic Investment from Global Medical Device Manufacturer to Support Clinics Treating Suicidal Depression and PTSD: NRx: (Stock Symbol: NRXP)
NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties
Read MoreNEXS BIOMEDICA CORPORATION Partners with Microsoft to Transform Biotechnology
ELKRIDGE, Md. - -- NEXS BIOMEDICA CORPORATION, a leading innovator in biotechnology and pharmaceutical development, today announced a groundbreaking strategic partnership with Microsoft. This collaboration aims to revolutionize drug discovery...
Read MoreSTEM Careers Unlocked Launches to Help STEM Professionals Fast-Track Career Success
LOS ANGELES - -- STEM Careers Unlocked, a new career and leadership newsletter designed for STEM professionals, has officially launched, offering exclusive insights and strategies to help early- and mid-career professionals accelerate their success in...
Read MoreLifenome Inc. and Optimo Life Launch Genetria, Transforming Precision Health and Longevity in Latin America
Joint venture combines AI-powered genomics with leading longevity care to bring precision health to Mexico and beyond.
Read MoreAce Therapeutics Accelerates Preclinical Psychiatry Research by Rolling Out Customized Animal Models
NEW YORK - -- As a preclinical contract research provider dedicated to offering comprehensive research services, Ace Therapeutics provides a complete one-stop service for developing custom animal models to support preclinical psychiatry research (https...
Read More$300 Million in Milestones; Double-Digit Royalties; Neurospa LOI for Expansion of International Psychiatry Clinics plus NDA Filed with FDA on New Drug
NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP): License and Distribution Terms Set for Lucrative Suicide Depression Treatment; $31 Price Target from Respected Investment Analyst D. Boral Capital
Read MoreMiBA Announces Key Leadership Team Appointment
Matt Hagan Named Vice President of Marketing and Client Innovation
Read MoreBSI excited to be chosen to attend Singapore Maritime week & SeaAsia with TMA BlueTech Trade Mission
The scientific instrument company is honored to be chosen as one of 12 innovative companies to help U.S. companies expand into international markets and connect with key partners at Singapore Maritime week and Sea Asia March 23-29th 2025.
Read MoreInavya Ventures Ltd Recognized Among the Most Innovative Companies to Watch in 2025 by The CEO Vision
LONDON - -- Inavya Ventures Ltd Recognized Among the Most Innovative Companies to Watch in 2025 by The CEO Vision The CEO Vision, a premier business magazine dedicated to recognizing trailblazing companies and leaders, proudly names Inavya Ventures Ltd...
Read More"National Employer Tax Reduction Month" Launched By HR Advisory Firm Employers HRx
Our Goal Is To Bring Awareness to Business Owners On Employment Taxes And How To Minimize Them
Read MoreNEXS BioMedica Unveils CancerScope-AI: A Game-Changer in Rare Cancer Treatment
ELKRIDGE, Md. - -- NEXS BioMedica, a forward-thinking biotech pharmaceutical company, proudly introduces CancerScope-AI, an innovative artificial intelligence system set to transform the battle against rare cancers. Developed alongside sister company...
Read MoreNeuroZenn now on GSA contract for Veteran Affairs Hospitals
NeuroZenn is now available for all Veterans to have prescribed for nerve pain at all veteran Affairs Hospitals.
Read MoreSano Chemicals Inc. (DBA "Sano Women's Health") Announces Approval to Start Phase 1 MAD Study
BRYAN, Texas - -- Sano Women's Health has received investigational new drug approval from the FDA, for Occidiofungin, a first-in-class novel peptide with broad antifungal activity. The FDA has also granted qualified infectious disease product (QIDP) and..
Read MoreCurtana Pharmaceuticals Announces Breakthrough in Pediatric Brain Cancer Treatment with Dual Studies Published in Nature Communications
AUSTIN, Texas - -- Curtana Pharmaceuticals, a biotechnology company focused on improving outcomes for brain cancer patients, is proud to announce the publication of two pioneering studies in Nature Communications. These studies highlight the potential...
Read MoreManhattan BioSolutions Initiates NCI PIVOT Collaboration in Pediatric Cancers
NEW YORK - -- Manhattan BioSolutions, Inc. ("MABS"), an emerging biotechnology company developing new classes of precision biologics that harness natural host defense mechanisms, today announced that its RNA-targeting therapeutic, MABS-139, will be...
Read MoreImprozo Inc. Making Waves in Healthcare with Tech-Driven Patient Focus
Disrupting the healthcare consulting landscape, Improzo Inc. is rapidly gaining traction with its innovative approach that tackles modern challenges and prioritizes patients.
Read MoreOak Therapeutics Develops Novel Oral Dissolvable Strips for Antiretroviral Therapy for Infants
LAWRENCE, Kan. - -- Oak Therapeutics, a pioneering early-stage life sciences company, announces the successful development of an innovative Oral Dissolvable Strip (ODS) formulation for the treatment of HIV/AIDS in infants and young children. This...
Read More